The challenge of drug-induced aseptic meningitis

Archives of Internal Medicine

Volumn 159, Issue 11, 1999, Pages 1185-1194

  Moris, German ^a   Garcia Monco, Juan Carlos ^b  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b HOSPITAL DE GALDAKAO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN; CIPROFLOXACIN; COTRIFAMOLE; CYTARABINE; DICLOFENAC; HEPATITIS B VACCINE; IBUPROFEN; IMMUNOGLOBULIN; ISONIAZID; KETOPROFEN; METRONIDAZOLE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OKT 3; PENICILLIN G; PHENAZOPYRIDINE; PYRAZINAMIDE; RANITIDINE; SALAZOSULFAPYRIDINE; SALICYLIC ACID; SULFAFURAZOLE; SULFAMETHIZOLE; SULINDAC; TOLMETIN; TRIMETHOPRIM; ZIMELDINE;

ASEPTIC MENINGITIS; CEREBROSPINAL FLUID EXAMINATION; DISEASE PREDISPOSITION; DRUG INDUCED DISEASE; HUMAN; MENINGITIS; PATHOGENESIS; PLEOCYTOSIS; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0033553892     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.11.1185     Document Type: Review

References (160)

1. Widener HL, Littman BL. Ibuprofen-induced meningitis in systemic lupus erythematosus. JAMA. 1978;239:1062-1064.
2. Wasner CK. Ibuprofen, meningitis and systemic lupus erythematosus. J Rheumatol. 1978; 5:162-164.
3. Samuelson CO, Williams HJ. Ibuprofen-associated aseptic meningitis in systemic lupus erythematosus. West J Med. 1979;131:57-59.
4. Bernstein RF. Ibuprofen-related meningitis in mixed connective tissue disease. Ann Intern Med. 1980;92:206.
5. Giansiracusa DF, Blumberg S, Kantrowitz FG. Aseptic meningitis associated with ibuprofen. Arch Intern Med. 1980;140:1553.
6. Ruppert GB, Barth WF. Ibuprofen hypersensitivity in a systemic lupus erythematosus. South Med J. 1981;74:241-243.
7. Peck MG, Joyner PU. Ibuproten-associated aseptic meningitis. Clin Pharmacol. 1982;1:561-565.
8. Quinn JP, Weinstein RA, Caplan LR. Eosinophilic meningitis and ibuprofen therapy. Neurology. 1984;34:108-109.
9. Perera DR, Seiffert AK, Greeley HM. Ibuprofen and meningoencephalitis. Ann Intern Med. 1984; 100:619.
10. Lawson JM, Grady MJ. Ibuprofen-induced aseptic meningitis in a previously healthy patient. West J Med. 1985;143:386-387.
11. Bouland DL, Specht NL, Hegstad DR. Ibuprofen and aseptic meningitis. Ann Intern Med. 1986; 104:731.
12. Mandell BF, Raps EC. Severe systemic hypersensitivity reaction to ibuprofen occurring after prolonged therapy. Am J Med. 1987;82:817-820.
13. Jensen S, Glud TK, Bacher T, Ersgaard H. Ibuprofen-induced meningitis in a male with systemic lupus erythematosus. Acta Med Scand. 1987;221:509-511.
14. Katona BG, Wigley FM, Walters JK, Caspi M. Aseptic meningitis from over-the-counter ibuprofen. Lancet. 1988;1:59.
15. Mifsud AJ. Drug-related recurrent meningitis. J Infect. 1988;17:151-153.
16. Durback MA, Freeman J, Schumacher HR. Recurrent ibuprofen-induced aseptic meningitis: third episode after only 200 mg of generic ibuprofen. Arthritis Rheum. 1988;31:813-815.
17. Gilbert GJ, Eichenbaum HW. Ibuprofen-induced meningitis in an elderly patient with systemic lupus erythematosus. South Med J. 1989; 82:514-515.
18. Ewert BH. Resident article: ibuprofen-associated meningitis in a woman with only serologic evidence of a reumathologic disorder. Am J Med Sci. 1989;297:326-327.
19. Grimm AM, Wolf JE. Aseptic meningitis associated with nonprescription ibuprofen use. DICP. 1989;23:712.
20. Chez M, Sila CA, Ransohoff RM, Longworth DL, Weida C. Ibuprofen-induced meningitis: detection of intrathecal IgG synthesis and immune complexes. Neurology. 1989;39:1578-1580.
21. Agus B, Nelson J, Kramer N, Mahal SS, Rosenstein ED. Acute central nervous system symptoms caused by ibuprofen in connective tissue disease. J Rheumatol. 1990;17:1094-1096.
22. Lortholary A, Varache N, Bouachour G, Szapiro N, Bourrier P, Alquier P. État de mal comitial généralisé après prise d'ibuproféne, révélateur d'un lupus érythémateux disséminé. Rev Med Interne. 1990;11:243-244.
23. Kaplan BH, Nevitt MP, Pach JM, Herman DC. Aseptic meningitis and iridocyclitis related to ibuprofen. Am J Opthalmol. 1994;117:119-120.
24. Eustace S, Buff B. Magnetic resonance imaging in drug-induced meningitis. Can Assoc Radiol J. 1994;45:463-465.
25. Hoffman M, Gray RG. Ibuprofen-induced meningitis in mixed connective tissue disease. Clin Rheumatol. 1982;1:128-130.
26. Peterson DI, Chong MJ. Recurrent meningitis due to nonsteroidal anti-inflammatory drugs. Bull Clin Neurosci. 1987;53:40-42.
27. Thilmann AF, Mobius E, Thilmann RR, Topper R. Recurrent aseptic meningitis (Mollaret meningitis): spontaneous and drug-induced origin. Fortschr Neurol Psychiatr. 1991;59:493-497.
28. Hanson L. Ibuprofen-induced aseptic meningitis. J Tenn Med Assoc. 1994;87:58.
29. Colamarino R, Soubrier M, Zenut-Leaud M, Prudat M, Tournillac M, Bussiere JC. Aseptic meningitis caused by ibuprofen (Nurofen) in connective tissue disease. Therapy. 1993;48:516-518.
30. Horn AC, Jarrert SW. Ibuprofen-induced aseptic meningitis in rheumatoid arthritis. Ann Pharmacother. 1997;31:1009-1011.
31. van der Zwan A, van Dam JG. Ibuprofen meningitis. Ned Tijdschr Geneeskd. 1992;136:1613-1614.
32. Ruppert GB, Barth WF. Tolmetin-induced aseptic meningitis. JAMA. 1981;245:67-68.
33. Ballas ZK, Donta ST. Sulindac-induced aseptic meningitis. Arch Intern Med. 1982;142:165-166.
34. Lorino GD, Hardin JG. Sulindac-induced meningitis in mixed connective tissue disease. South Med J. 1983;76:1185-1187.
35. Von Reyn CF. Recurrent aseptic meningitis due to sulindac. Ann Intern Med. 1983;99:343-344.
36. Neufeld MY, Korczyn AD. Encephalopathy associated with sulindac. Hum Toxicol. 1986;5:55.
37. Yasuda Y, Akiguchi I, Kameyama M. Sulindac-induced aseptic meningitis in mixed connective tissue disease. Clin Neurol Neurosurg. 1989;91: 257-260.
38. Greenberg GN. Recurrent sulindac-induced aseptic meningitis in a patient tolerant to other nonsteroidal anti-inflammatory drugs. South Med J. 1988;81:1463-1464.
39. Sylvia LM, Forlenza SW, Brocavich JM. Aseptic meningitis associated with naproxen. DICP. 1988; 22:399-401.
40. Roel JE, Gadano AC, Falcon JL. Ketoprofen and aseptic meningitis. Medicina (B Aires). 1991;51: 186.
41. Weksler BB, Lehany AM. Naproxen-induced recurrent aseptic meningitis. Ann Pharmacother. 1991;25:1183-1184.
42. Codding C, Targoff IN, McCarty GA. Aseptic meningitis in association with diclofenac treatment in a patient with systemic lupus erythematosus. Arthritis Rheum. 1991;34:1340-1341.
43. Barret PVD, Thier SO. Meningitis and pancreatitis associated with sulfamethizole. N Engl J Med. 1963;268:36-37.
44. Kremer I, Ritz R, Brunner F. Aseptic meningitis as an adverse effect of co-trimoxazole. N Engl J Med. 1983;308:1481.
45. Haas EJ. Trimethoprim-sulfamethoxazole: another cause of recurrent meningitis. JAMA. 1984; 252:346.
46. Biosca M, de la Figuera M, García-Bragado F, Sampol G. Aseptic meningitis due to trimethoprim-sulfamethoxazole. J Neurol Neurosurg Psychiatry. 1986;49:332-333.
47. Streiffer RH, Hudson JG. Aseptic meningitis and trimethoprim-sulfamethoxazole. J Fam Pract. 1986;23:314.
48. Joffe AM, Farley JD, Linden D, Goldsand G. Trimethoprim-sulfamethoxazole associated aseptic meningitis: case reports and review of the literature. Am J Med. 1989;87:332-338.
49. Gordon MF, Allon M, Coyle PK. Drug-induced meningitis. Neurology. 1990;40:163-164.
50. Auxier GG. Aseptic meningitis associated with administration of trimethoprim and sulfamethoxazole. AJDC. 1990;144:144-145.
51. Tunkel AR, Starr K. Trimethoprim-sulfamethoxazole-associated aseptic meningitis. Am J Med. 1990;88:696.
52. Escalante A, Stimmler MM. Trimethoprim-sulfamethoxazole induced meningitis in systemic lupus erythematosus. J Rheumatol. 1992; 19:800-802.
53. Davis JD, Thompson J, Peimann BS, Bendixen BH. Drug-induced aseptic meningitis caused by two medications. Neurology. 1994;44:984-985.
54. Wong JG, Hathaway SC, Paat JJ, Paterson RW, Steele Jr GH. Drug-induced meningitis: a case involving trimethoprim-sulfamethoxazole. Post-grad Med. 1994;96:117-124.
55. River Y, Averbuch-Heller L, Weinberger M, et al. Antibiotic induced meningitis. J Neurol Neurosurg Psychiatry. 1994;57:705-708.
56. Carrillo F, Cubero A, Hernádez Gallego J, Jiménez Santana P. Meningoencefalitis recurrente inducida por cotrimoxazol. Rev Neurol. 1995;23: 142-144.
57. Rudy BJ, Rutsein R. Aseptic meningitis from trimethoprim-sulfamethoxazole in an HIV-infected adolescent. Pediatr Emerg Care. 1997;13: 216-217.
58. Blumenfeld H, Cha JH, Cudkowicz ME. Trimethoprim and sulfonamide-associated meningoencephalitis with MRI correlates. Neurology. 1996; 46:556-558.
59. Pashankar D, McArdle M, Robinson A. Co-trimoxazole induced aseptic meningitis. Arch Dis Child. 1995;73:257-258.
60. Poles L, Theodor E. Trimethoprim-sulfamethoxazole-induced meningitis. Harefuah. 1996;130: 817-818.
61. Jurado R, Carpenter SL, Rimland D. Case reports: trimethoprim-sulfamethoxazole-induced meningitis in patients with HIV infection. Am J Med Sci. 1996;312:27-29.
62. Derbes SJ. Trimethoprim-induced aseptic meningitis. JAMA. 1984;252:2865-2866.
63. Carlson J, Wihlom B. Trimethoprim-associated aseptic meningitis. Scand J Infect Dis. 1987;19: 687-691.
64. Hedlund J, Aurelius E, Andersson J. Recurrent encephalitis due to trimethoprim intake. Scand J Infect Dis. 1990;22:109-112.
65. Harrison MS, Simonte SJ, Kauffman CA. Trimethoprim-induced aseptic meningitis in a patient with AIDS: case report and review. Clin Infect Dis. 1994;19:431-434.
66. Gilroy N, Gottlieb T, Spring P, Peiris O. Trimethoprim-induced aseptic meningitis and uveitis. Lancet. 1997;350:112.
67. Saha H, Lumio J, Pasternack A. Acute aseptic meningitis induced by trimethoprim. Duodecim. 1998;104:257-261.
68. Garagusi VF, Neefe LI, Mann O. Acute meningoencephalitis: association with isoniazid administration. JAMA. 1976;235:1141-1142.
69. Asperilla MO, Smego MD. Eosinophilic meningitis associated with ciprofloxacin. Am J Med. 1989;87:589-590.
70. Corson AP, Chretien JH. Metronidazole-associated aseptic meningitis. Clin Infect Dis. 1994; 19:974.
71. Sundstrom O, Svedberg LE, Carling L. Meningitretning efter Metronidazol. Lakartidningen. 1984;81:3480.
72. Creel GB, Hurtt M. Cephalosporin-induced recurrent aseptic meningitis. Ann Neurol. 1995; 37:815-817.
73. Bodokh I, Lacour J, Costa I, Botcazou V, Chichmanian RM, Ortonne JP. Meningite aseptique sous pyrazinamide lors de lupus erythemateux. Presse Med. 1993;22:595-596.
74. Kato E, Shindo S, Eto Y, et al. Administration of immune globulin associated with aseptic meningitis. JAMA. 1988;259:3269-3271.
75. Casteels-Van Daele M, Wijndaele L, Hunninck K, Gillis P. Intravenous immune globulin and acute aseptic meningitis. N Engl Med. 1990;323:614-615.
76. Vera-Ramirez M, Charlet M, Parry GJ. Recurrent aseptic meningitis complicating intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy. Neurology. 1992;42:1636-1637.
77. Watson JDG, Gibson J, Joshua DE, Kronenberg H. Aseptic meningitis associated with high dose intravenous immunoglobulin therapy. J Neurol Neurosurg Psychiatry. 1991;54:275-276.
78. Pallares DE, Marshall FS. Acute aseptic meningitis associated with administration of intravenous immune globulin. Am J Pediatr Hematol Oncol. 1992;14:279.
79. Molina J-M, Coffineau A, Rain J-D, Letonturier D, Modai J. Aseptic meningitis following administration of intravenous immune globulin. Clin Infect Dis. 1992;15:564-565.
80. Meiner Z, Ben-Hur T, River Y, Reches A. Aseptic meningitis as complication of intravenous immunoglobulin therapy for myasthenia gravis. J Neurol Neurosurg Psychiatry. 1993;56:830-831.
81. De Vlieghere FC, Peetermans WE, Vermylen J. Aseptic granulocytic meningitis following treatment with intravenous immunoglobulin. Clin Infect Dis. 1994;18:1008.
82. Sekul EA, Cupler EJ, Dalakas MC. Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors. Ann Intern Med. 1994;121:159-262.
83. Mitterer M, Pescosta N, Vogetseder W, Mair M, Coser P. Two episodes of aseptic meningitis during intravenous immunoglobulin therapy of idiopathic thrombocytopenic purpura. Ann Hematol. 1993;67:151-152.
84. Jayabose S, Roseman B, Gupta A. "Aseptic meningitis syndrome" after intravenous gammaglobulin therapy for ITP. Am J Hematol Oncol. 1990;12:117.
85. Rao SP, Teitlebaum J, Miller ST. Intravenous immune globulin and aseptic meningitis. AJDC. 1992;146:539-540.
86. Ellis RJ, Swenson MR, Bajorek J. Aseptic meningitis as a complication of intravenous immunoglobulin therapy for myasthenia gravis. Muscle Nerve. 1994;17:683-684.
87. Oddou S, Molinier S, Coso D, Boulet JM, Gastaut JA, Bouabdallah R. Méningite aseptique consécutive à un traitement par immunoglobulines: intéret physiopathologique et pronostique de son déspistage. Presse Med. 1995;24:916.
88. Preminger-Shapiro R, Nussinovich M, Soen G, Varsano I. Aseptic meningitis: a frequent side-effect of intravenous immunoglobulin? Eur J Pediatr. 1995;154:866-867.
89. Mselati JC, Carlier JC, Routon MC, Noui Mehidi F, de Gennes C. Immunoglobulines intraveineuses et méningite aseptique. Arch Fr Pediatr. 1992; 49:216.
90. Sirvent N, Monpoux F, Benet L, Mariani R. Méningite aseptique au cours d'un traitement par immunoglobulines. Arch Pediatr. 1996;3:830-831.
91. Kressebuch H, Schaad UB, Hirt A, Bianchetti MG. Cerebrospinal fluid inflammation induced by intravenous immunoglobulins. Pediatr Infect Dis J. 1992;11:894-895.
92. Bussel J, Cunningham-Rundles C, Feldman C, Horowitz B. Transmission of viral infection by preparations of intravenous immunoglobulin. Plasma Ther Transfus Technol. 1988;9:193-205.
93. Fernández-Carril JM, Trejo JM, Sedano MJ, Goñi M. Meningitis aséptica por inmunoglobulinas intravenosas. Neurología. 1995;10:351-352.
94. Gabor EP. Intravenous immune globulins. West J Med. 1995;162:277-278.
95. Shorr AF, Kester KE. Meningitis and hepatitis complicating intravenous immunoglobulin therapy. Ann Pharmacother. 1996;30:1115-1116.
96. Kattamis AC, Shankar S, Cohen AR. Neurological complications of treatment of childhood acute immune thrombocytopenic purpura with intravenously administered immunoglobulin G. J Pediatr. 1997;130:281-283.
97. Picton P, Chishol M. Aseptic meningitis associated with high dose immunoglobulin: case report. BMJ. 1997;315:1203-1204.
98. Lafferty TE, DeHoratius RJ, Smith JB. Aseptic meningitis as a side effect of intravenous immune gammaglobulin. J Rheumatol. 1997;24: 2491-2492.
99. Van der Merché F, Kleyweg R. Aseptic meningitis associated with high dose intravenous immunoglobulin therapy. J Neurol Neurosurg Psychiatry. 1992;55:981.
100. Emmons C, Smith J, Flanigan M. Cerebrospinal fluid inflammation during OKT3 therapy. Lancet. 1986;2:510-511.
101. Roden J, Klintmalm GBG, Husberg BS, Nery J, Olson LM. Cerebrospinal fluid inflammation during OKT3 therapy. Lancet. 1987;2:272.
102. Thistlethwaite JR, Gaber AO, Haag BW, et al. OKT3 treatment of steroid-resistant renal allograft rejection. Transplantation. 1987;43:176-184.
103. Rello J, Vallverdü I, Coll P, Gurgí M, Net A. Aseptic meningitis associated with muromonab-CD3. DICP. 1990;24:1233.
104. Joy ME, Michals ML, Canatax DM. Aseptic meningitis associated with muromonab-CD3 therapy. Clin Pharmacol. 1988;7:721.
105. Figg WD. Aseptic meningitis associated with muromonab-CD3. DICP. 1991;25:1395.
106. Strominger MB, Liu GT, Schartz NJ. Optic disk swelling and abducens palsies associated with OKT3. Am J Ophthalmol. 1995;119:664-665.
107. Costanzo-Nordin MR, Silver MA, O'Conell JB, et al. Successful reversal of acute cardiac allograft rejection with OKT3 monoclonal antibody. Circulation. 1987;76(suppl 5):71-80.
108. Thistlethwaite JR, Stuart JK, Mayes JT, et al. Monitoring and complications of monoclonal therapy: complications and monitoring of OKT3 therapy. Am J Kidney Dis. 1988;11:112-119.
109. Coleman AE, Norman DJ. OKT3 encephalophaty. Ann Neurol. 1990;28:837-838.
110. Adair JC, Woodley SL, O'Conell JB, Call GK, Baringer JR. Aseptic meningitis following cardiac transplantation: clinical characteristics and relationship to immunosuppressive regimen. Neurology. 1991;41:249-252.
111. Chan GL, Weinstein SS, Wright CE, et al. Encephalopathy associated with OKT3 administration: possible interaction with indomethacin. Transplantation. 1991;52:148-150.
112. Thomas DM, Nicholls AJ, Feest TG, Riad H. OKT3 and cerebral oedema. BMJ. 1987;295:1486.
113. Capone PM, Cohen ME. Seizures and cerebritis associated with administration of OKT3. Pediatr Neurol. 1991;7:299-301.
114. Osterman JD, Trauner DA, Reznik VM, Lemire J. Transient hemiparesis associated with monoclonal CD3 antibody (OKT3) therapy. Pediatr Neurol. 1993;9:482-484.
115. Agarwal RK, Ostaszewski ML, Feld LG, Springate JE, Moxey-Mims MM, O'Neill KM. Tumor necrosis factor and interleukin-6 in cerebrospinal fluid of a patient with recurrent adverse central nervous system events following OKT3. Transplant Proc. 1993;25:3143-3144.
116. Kormos RL, Arnitage JM, Dummer JS, Miyamoto Y, Griffith BP, Hardesty RL. Optimal perioperative immunosuppression in cardiac transplantation using rabbit antithymocyte globulin. Transplantation. 1990;49:306-311.
117. Massanari R, Martin M, Smith J, et al. Aseptic meningitis among kidney transplant recipients receiving a newly marketed murine monoclonal antibody preparation. JAMA. 1986;256:1873.
118. Uribe Roca MC, Zurru MC, Gatto EM, Maggiora EC, Agost Carreno C, Luciano M. Aseptic meningitis due to OKT3. Neurologia. 1998;13:98-99.
119. Rizzo JD, Rowe SA. Meningism in a ten-month-old infant during OKT3 therapy. J Heart Transplant. 1990;9:727-728.
120. Farmer L, Echlin FA, Loughin WC, Breakey AS, Duvoisin R. Pachymeningitis apparently due to penicillin hypersensitivity. Ann Intern Med. 1960; 54:910-914.
121. Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults: a review of 493 episodes. N Engl J Med. 1993;328:21-28.
122. Barrons RW, Murray KM, Richey RM. Populations at risk for penicillin-induced seizures. Ann Pharmacother. 1992;26:26-29.
123. Stewart WF, Lipton RB, Celentano DD, et al. Prevalence of migraine headache in the United States. JAMA. 1992;267:64-69.
124. Montalbán J, Cervera R, Font J, et al. Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus. Neurology. 1992;42:681-682.
125. Markus HS, Hopkinson N. Migraine and headache in systemic lupus erythematosus and their relationship with antibodies against phospholipids. J Neurol. 1992;239:39-42.
126. Geiseler PJ, Nelson KE, Levin S, Reddi KT, Moses VK. Community-acquired purulent meningitis: a review of 1316 cases during the antibiotic era, 1954-1976. Rev Infect Dis. 1980;2:725-745.
127. Roos KL, Tunkel AR, Scheld WM. Acute bacterial meningitis in children and adults. In: Scheld WM, Whitley RJ, Durack DT, eds. Infections of the Central Nervous System. New York, NY: Raven Press; 1991:335-409.
128. Connolly KJ, Hammer SM. The acute aseptic meningitis syndrome. Infect Dis Clin North Am. 1990;4:599-622.
129. Jeffery KJM, Read SJ, Peto TEA, Mayon-White RT, Bangham CRM. Diagnosis of viral infections of the central nervous system: clinical interpretation of PCR results. Lancet. 1997;349: 313-317.
130. Ellis SG, Verity MA. Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955-1977. Semin Arthritis Rheum. 1979;8:212-221.
131. Gibson T, Myers AR. Nervous system involvement in systemic lupus erythematosus. Ann Rheum Dis. 1975;35:398-406.
132. Canoso JJ, Cohen AS. Aseptic meningitis in systemic lupus erythematosus. Arthritis Rheum. 1975;18:369-373.
133. Kovacs K, Bors L, Tóthfalusi L, et al. Cerebrospinal fluid investigations in migraine. Cephalagia. 1989;9:53-57.
134. Gómez-Aranda F, Cañadillas F, Martí-Massó JF, et al. Pseudomigraine with temporary neurological symptoms and lymphocytic pleocytosis. Brain. 1997;120:1105-1113.
135. Brooks PM, Day RO. Nonsteroidal anti-inflammatory drugs: differences and similarities. N Engl J Med. 1991;324:1716-1725.
136. Berliner S, Weisberg A, Schoenfeld Y. Ibuprofen may induce meningitis in (NZB × NZW) F1 mice. Arthritis Rheum. 1985;28:104-107.
137. Shoenfeld Y, Livni E, Shaklai M, Pinkhas J. Sensitization to ibuprofen in systemic lupus erythematosus. JAMA. 1980;244:547-548.
138. Fauci AS, Steinberg AD, Haynes BF, et al. Immunoregulatory aberrations in systemic lupus erythematosus. J Immunol. 1978;121:1473-1474.
139. Derbes SJ. Aseptic meningitis, trimethoprim, and Sjögren's syndrome. JAMA. 1985;253: 2192.
140. de la Monte SM, Hutchins GM, Gupta PK. Aseptic meningitis, trimethoprim, and Sjögren's syndrome. JAMA. 1985;253:2192.
141. Dalakas MC. Aseptic meningitis and intravenous inmmunoglobulin therapy. Ann Itern Med. 1995;122:316-317.
142. Scribner CL, Kapit RM, Phillips ET, Rickles NM. Aseptic meningitis and intravenous immunoglobulin therapy. Ann Intern Med. 1994;121: 105-306.
143. Martin MA, Massanari RM, Nghiem DD, Smith JL, Cany RT. Nosocomial aseptic meningitis associated with administration of OKT3. JAMA. 1988;259:2002-2005.
144. Chatenaud L, Ferran C, Legendre C, et al. In vivo cell activation following OKT3 administration. Transplantation. 1990;49:692-702.
145. Charpentier B, Hiesse C, Ferran C, et al. Acute clinical syndrome associated with OKT3 administration: prevention by single injection of an antihuman TNF monoclonal antibody. Presse Med. 1991;20:2009-2011.
146. Williams AF, Gagnon J. Neuronal cell thy-1 glycoprotein: homology with immunoglobulin. Science. 1982;216:696-703.
147. Bienbaum G. Studies on brain thymus cross-reactive antigens. Brain Res. 1975:84:111-121.
148. Hilton E, Stroh EM. Aseptic meningitis associated with administration of carbamazepine. J Infect Dis. 1989;159:363-364.
149. Simon LT, Hsu B, Dornato BT. Carbamazepine-induced aseptic meningitis. Ann Intern Med. 1990;112:627-628.
150. Hemet C, Chassagne P, Levade M, et al. Aseptic meningitis secondary to carbamazepine treatment of manic-depressive illness. Am J Psychiatry. 1994;151:1393.
151. Dang CT, Riley DK. Aseptic meningitis secondary to carbamazepine therapy. Clin Infect Dis. 1996;22:729-730.
152. Merrin P, Williams IA. Meningitis associated with sulphasalazine in a patient with Sjögren's syndrome and polyarthritis. Ann Rheum Dis. 1991; 50:645-646.
153. Alloway JA, Mitchell SR. Sulfasalazine neurotoxicity: a report of aseptic meningitis and a review of the literature. J Rheumatol. 1993;20:409-411.
154. Herlihy TE. Phenazopiridine and aseptic meningitis. Ann Intern Med. 1987;106:172-135.
155. Swedish Adverse Drug Reactions Advisory Committee. Survey of Adverse Effects: Zimeldin. Swedish Adverse Drug Reactions Advisory Committee: 1983. Bulletin 39/40.
156. Thordarson H, Talstad I. Acute meningitis and cerebellar dysfunction complicating high-dose cytosine arabinoside therapy. Acta Med Scand. 1986;220:493-495.
157. Sergent JS, Lockshin MD, Klemper MS, Lipsky BA. Central nervous system disease in systemic lupus erythematosus: therapy and prognosis. Am J Med 1975;58:644-654.
158. Nair J, Stacy M. Aseptic meningitis associated with salicylate overdose. Psychosomatics. 1993; 34:372.
159. Heinzlef O, Moguilewski A, Roullet E. Meningite aigue aseptique apres vaccination contre l'hepatite B. Presse Med. 1997;26:328.
160. Durand JM, Suchet L. Ranitidine and aseptic meningitis. BMJ. 1997;312:886.